carvedilol has been researched along with dihydroxyfumarate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feuerstein, G; McKenna, PJ; Ruffolo, RR; Yue, TL | 1 |
1 other study(ies) available for carvedilol and dihydroxyfumarate
Article | Year |
---|---|
Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Carbazoles; Carvedilol; Free Radical Scavengers; Fumarates; Humans; In Vitro Techniques; Lipid Peroxidation; Neutrophils; Propanolamines; Superoxides; Tetradecanoylphorbol Acetate; Vasodilator Agents | 1992 |